SLC5A2 and focal segmental glomerulosclerosis: Since IgAN and FSGS are common causes of pediatric CKD of glomerular origin, pediatric nephrologists believe that SGLT2 inhibitors could potentially be beneficial for the pediatric CKD population [15, 16].